Authors: Tzachanis, D Freeman, GJ Hirano, N van Puijenbroek, AAFL Delfs, MW Berezovskaya, A Nadler, LM Boussiotis, VA

Citation: D. Tzachanis et al., Tob is a negative regulator of activation that is expressed in anergic andquiescent T cells, NAT IMMUNOL, 2(12), 2001, pp. 1174-1182

Authors: Appleman, LJ Tzachanis, D Grader-Beck, T van Puijenbroek, AAFL Boussiotis, VA

Citation: Lj. Appleman et al., Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics, J MOL MED-J, 78(12), 2001, pp. 673-683

Authors: van Puijenbroek, AAFL Wissink, S van der Saag, PT Peppelenbosch, MP

Citation: Aafl. Van Puijenbroek et al., Phospholipase A(2) inhibitors and leukotriene synthesis inhibitors block TNF-induced NF-kappa B activation, CYTOKINE, 11(2), 1999, pp. 104-110

Authors: van Puijenbroek, AAFL van der Saag, PT Coffer, PJ

Citation: Aafl. Van Puijenbroek et al., Cytokine signal transduction in P19 embryonal carcinoma cells: Regulation of Stat3-mediated transactivation occurs independently of p21ras-Erk signaling, EXP CELL RE, 251(2), 1999, pp. 465-476